Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1985 Dec;331(4):364-8.
doi: 10.1007/BF00500821.

On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin

Comparative Study

On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin

W Piotrowski et al. Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec.

Abstract

Substance P (SP), somatostatin (Som), and vasoactive intestinal polypeptide (VIP) induced a concentration-dependent release of histamine from isolated rat peritoneal mast cells. The release of histamine induced by these neuropeptides was inhibited by preincubation of the cells with the SP analogue [D-Pro4,D-Trp7,9,10]-SP4-11 (SP-A) (10 microM), and also by benzalkonium chloride (10 microM). In addition, SP-A inhibited histamine release induced by compound 48/80, whilst that induced by goat anti-(rat-IgE) was unaffected. In human skin, intradermal injection of SP, Som, or VIP produced flare and wheal responses. The flares to all three peptides were inhibited by preinjection of the skin with SP-A (25 pmol), whilst the wheal responses were unaffected. It is concluded that the receptors mediating histamine release and the flare response are similar, and that SP, Som, and VIP are acting at a similar receptor to produce these effects. It is probable that this receptor is also the site of action of compound 48/80.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Pharmacol. 1981 Jan 16;69(2):127-37 - PubMed
    1. J Physiol. 1983 Feb;335:449-65 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):67-70 - PubMed
    1. Eur J Pharmacol. 1984 Jan 27;97(3-4):179-89 - PubMed
    1. Int J Pept Protein Res. 1982 Oct;20(4):351-65 - PubMed

Publication types

MeSH terms